Generation and Use of Recombinant Galectins.

galectin galectin stability galectin-1 alkylation using iodoacetamide galectin-4 galectin-7 galectin-9 purification using Tris buffer lactosyl-sepharose chromatography stable and active galectin-9

Journal

Current protocols
ISSN: 2691-1299
Titre abrégé: Curr Protoc
Pays: United States
ID NLM: 101773894

Informations de publication

Date de publication:
Mar 2021
Historique:
entrez: 3 3 2021
pubmed: 4 3 2021
medline: 22 6 2021
Statut: ppublish

Résumé

Galectins are soluble carbohydrate binding proteins that can bind β-galactose-containing glycoconjugates by means of a conserved carbohydrate recognition domain (CRD). In mammalian systems, galectins have been shown to mediate very important roles in innate and adaptive immunity as well as facilitating host-pathogen relationships. Many of these studies have relied on purified recombinant galectins to uncover key features of galectin biology. A major limitation to this approach is that certain recombinant galectins purified using standard protocols are easily susceptible to loss of glycan-binding activity. As a result, biochemical studies that employ recombinant galectins can be misleading if the overall activity of a galectin remains unknown in a given assay condition. This article examines fundamental considerations when purifying galectins by lactosyl-sepharose and nickel-NTA affinity chromatography using human galectin-4N and -7 as examples, respectively. As other approaches are also commonly applied to galectin purification, we also discuss alternative strategies to galectin purification, using human galectin-1 and -9 as examples. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Purification of galectins using lactosyl-sepharose affinity chromatography Basic Protocol 2: Purification of human galectin-7 using a nickel-NTA affinity chromatography column Alternate Protocol 1: Iodoacetamide alkylation of free sulfhydryls on galectin-1 Alternate Protocol 2: Purification of human galectin-9 using lactosyl-sepharose column chromatography.

Identifiants

pubmed: 33656274
doi: 10.1002/cpz1.63
doi:

Substances chimiques

Carbohydrates 0
Galectins 0
Galactose X2RN3Q8DNE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e63

Subventions

Organisme : NIH HHS
ID : DP5 OD019892
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL066987
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA242109
Pays : United States
Organisme : NIH HHS
ID : U01 CA242109
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Arthur, C. M., Baruffi, M. D., Cummings, R. D., & Stowell, S. R. (2015). Evolving mechanistic insights into galectin functions. Methods in Molecular Biology, 1207, 1-35. doi: 10.1007/978-1-4939-1396-1_1.
Arthur, C. M., Rodrigues, L. C., Baruffi, M. D., Sullivan, H. C., Heimburg-Molinaro, J., Smith, D. F., … Stowell, S. R. (2015). Examining galectin binding specificity using glycan microarrays. Methods in Molecular Biology, 1207, 115-131. doi: 10.1007/978-1-4939-1396-1_8.
Barondes, S. H., Castronovo, V., Cooper, D. N., Cummings, R. D., Drickamer, K., Feizi, T., et al. (1994). Galectins: A family of animal beta-galactoside-binding lectins. Cell, 76(4), 597-598. doi: 10.1016/0092-8674(94)90498-7.
Braakman, I., Helenius, J., & Helenius, A. (1992). Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum. EMBO Journal, 11(5), 1717-1722.
Clerch, L. B., Whitney, P., Hass, M., Brew, K., Miller, T., Werner, R., & Massaro, D. (1988). Sequence of a full-length cDNA for rat lung beta-galactoside-binding protein: Primary and secondary structure of the lectin. Biochemistry, 27(2), 692-699. doi: 10.1021/bi00402a030.
Cooper, D. N., & Barondes, S. H. (1990). Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. Journal of Cell Biology, 110(5), 1681-1691. doi: 10.1083/jcb.110.5.1681.
Cummings, R. D., Fu-Tong, L., & Vasta, G. R. (2017). Galectins. In A. Varki (Ed.), Essentials of glycobiology (3rd ed., pp. 2015-2017). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
de Waard, A., Hickman, S., & Kornfeld, S. (1976). Isolation and properties of beta-galactoside binding lectins of calf heart and lung. Journal of Biological Chemistry, 251(23), 7581-7587.
Elola, M. T., Ferragut, F., Mendez-Huergo, S. P., Croci, D. O., Bracalente, C., & Rabinovich, G. A. (2018). Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment. Cellular Immunology, 333, 34-45. doi: 10.1016/j.cellimm.2018.03.008.
Go, Y. M., & Jones, D. P. (2013). Thiol/disulfide redox states in signaling and sensing. Critical Reviews in Biochemistry and Molecular Biology, 48(2), 173-181. doi: 10.3109/10409238.2013.764840.
Hirashima, M., Kashio, Y., Nishi, N., Yamauchi, A., Imaizumi, T. A., Kageshita, T., … Nakamura, T. (2002). Galectin-9 in physiological and pathological conditions. Glycoconjugate Journal, 19(7-9), 593-600. doi: 10.1023/B:GLYC.0000014090.63206.2f.
Hsieh, T. J., Lin, H. Y., Tu, Z., Huang, B. S., Wu, S. C., & Lin, C. H. (2015). Structural basis underlying the binding preference of human galectins-1, -3 and -7 for Galβ1-3/4GlcNAc. PLoS One, 10(5), e0125946. doi: 10.1371/journal.pone.0125946.
Hsieh, T. J., Lin, H. Y., Tu, Z., Lin, T. C., Wu, S. C., Tseng, Y. Y., … Lin, C. H. (2016). Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors. Scientific Reports, 6, 29457. doi: 10.1038/srep29457.
Hughes, R. C. (1999). Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochimica Et Biophysica Acta, 1473(1), 172-185. doi: 10.1016/s0304-4165(99)00177-4.
Kamili, N. A., Arthur, C. M., Gerner-Smidt, C., Tafesse, E., Blenda, A., Dias-Baruffi, M., & Stowell, S. R. (2016). Key regulators of galectin-glycan interactions. Proteomics, 16(24), 3111-3125. doi: 10.1002/pmic.201600116.
LaVallie, E. R., DiBlasio, E. A., Kovacic, S., Grant, K. L., Schendel, P. F., & McCoy, J. M. (1993). A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Bio/Technology, 11(2), 187-193. doi: 10.1038/nbt0293-187.
Levi, G., & Teichberg, V. I. (1981). Isolation and physicochemical characterization of electrolectin, a beta-D-galactoside binding lectin from the electric organ of Electrophorus electricus. Journal of Biological Chemistry, 256(11), 5735-5740.
Matsushita, N., Nishi, N., Seki, M., Matsumoto, R., Kuwabara, I., Liu, F. T., … Hirashima, M. (2000). Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction. Journal of Biological Chemistry, 275(12), 8355-8360. doi: 10.1074/jbc.275.12.8355.
Nishi, N., Itoh, A., Fujiyama, A., Yoshida, N., Araya, S., Hirashima, M., … Nakamura, T. (2005). Development of highly stable galectins: Truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins. FEBS Letters, 579(10), 2058-2064. doi: 10.1016/j.febslet.2005.02.054.
Nishi, N., Itoh, A., Shoji, H., Miyanaka, H., & Nakamura, T. (2006). Galectin-8 and galectin-9 are novel substrates for thrombin. Glycobiology, 16(11), 15C-20C. doi: 10.1093/glycob/cwl028.
Perillo, N. L., Pace, K. E., Seilhamer, J. J., & Baum, L. G. (1995). Apoptosis of T cells mediated by galectin-1. Nature, 378(6558), 736-739. doi: 10.1038/378736a0.
Porath, J., Carlsson, J., Olsson, I., & Belfrage, G. (1975). Metal chelate affinity chromatography, a new approach to protein fractionation. Nature, 258(5536), 598-599. doi: 10.1038/258598a0.
Robinson, B. S., Arthur, C. M., Evavold, B., Roback, E., Kamili, N. A., Stowell, C. S., … Stowell, S. R. (2019). The sweet-side of leukocytes: Galectins as master regulators of neutrophil function. Frontiers in Immunology, 10, 1762. doi: 10.3389/fimmu.2019.01762.
Robinson, B. S., Arthur, C. M., Kamili, N. A., & Stowell, S. R. (2018). Galectin regulation of host microbial interactions. Trends in Glycoscience and Glycotechnology, 30(172), SE185-SE198. doi: 10.4052/tigg.1738.1SE.
Robinson, B. S., Saeedi, B., Arthur, C. M., Owens, J., Naudin, C., Ahmed, N., … Stowell, S. R. (2020). Galectin-9 is a novel regulator of epithelial restitution. American Journal of Pathology, 190(8), 1657-1666. doi: 10.1016/j.ajpath.2020.04.010.
St-Pierre, G., Rancourt, A., & Sato, S. (2020). Metazoan soluble beta-galactoside-binding lectins, galectins: methods for purification, characterization of their carbohydrate-binding specificity, and probing their ligands. Methods in Molecular Biology, 2132, 39-54. doi: 10.1007/978-1-0716-0430-4_5.
Stowell, S. R., Arthur, C. M., Cummings, R. D., & Feasley, C. L. (2015). Alkylation of galectin-1 with iodoacetamide and mass spectrometric mapping of the sites of incorporation. Methods in Molecular Biology, 1207, 51-62. doi: 10.1007/978-1-4939-1396-1_3.
Stowell, S. R., Arthur, C. M., Dias-Baruffi, M., Rodrigues, L. C., Gourdine, J. P., Heimburg-Molinaro, J., … Cummings, R. D. (2010). Innate immune lectins kill bacteria expressing blood group antigen. Nature Medicine, 16(3), 295-301. doi: 10.1038/nm.2103.
Stowell, S. R., Arthur, C. M., McBride, R., Berger, O., Razi, N., Heimburg-Molinaro, J., … Cummings, R. D. (2014). Microbial glycan microarrays define key features of host-microbial interactions. Nature Chemical Biology, 10(6), 470-476. doi: 10.1038/nchembio.1525.
Stowell, S. R., Arthur, C. M., Mehta, P., Slanina, K. A., Blixt, O., Leffler, H., … Cummings, R. D. (2008). Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. Journal of Biological Chemistry, 283(15), 10109-10123. doi: 10.1074/jbc.M709545200.
Stowell, S. R., Cho, M., Feasley, C. L., Arthur, C. M., Song, X., Colucci, J. K., … Cummings, R. D. (2009). Ligand reduces galectin-1 sensitivity to oxidative inactivation by enhancing dimer formation. Journal of Biological Chemistry, 284(8), 4989-4999. doi: 10.1074/jbc.M808925200.
Stowell, S. R., Dias-Baruffi, M., Penttila, L., Renkonen, O., Nyame, A. K., & Cummings, R. D. (2004). Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides. Glycobiology, 14(2), 157-167. doi: 10.1093/glycob/cwh018.
Stowell, S. R., Karmakar, S., Arthur, C. M., Ju, T., Rodrigues, L. C., Riul, T. B., … Cummings, R. D. (2009). Galectin-1 induces reversible phosphatidylserine exposure at the plasma membrane. Molecular Biology of the Cell, 20(5), 1408-1418. doi: 10.1091/mbc.E08-07-0786.
Stowell, S. R., Karmakar, S., Stowell, C. J., Dias-Baruffi, M., McEver, R. P., & Cummings, R. D. (2007). Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells. Blood, 109(1), 219-227. doi: 10.1182/blood-2006-03-007153.
Stowell, S. R., Qian, Y., Karmakar, S., Koyama, N. S., Dias-Baruffi, M., Leffler, H., … Cummings, R. D. (2008). Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. Journal of Immunology, 180(5), 3091-3102. doi: 10.4049/jimmunol.180.5.3091.
Sundblad, V., Morosi, L. G., Geffner, J. R., & Rabinovich, G. A. (2017). Galectin-1: A jack-of-all-trades in the resolution of acute and chronic inflammation. Journal of Immunology, 199(11), 3721-3730. doi: 10.4049/jimmunol.1701172.
Tartier, L., McCarey, Y. L., Biaglow, J. E., Kochevar, I. E., & Held, K. D. (2000). Apoptosis induced by dithiothreitol in HL-60 cells shows early activation of caspase 3 and is independent of mitochondria. Cell Death and Differentiation, 7(10), 1002-1010. doi: 10.1038/sj.cdd.4400726.
Toscano, M. A., Bianco, G. A., Ilarregui, J. M., Croci, D. O., Correale, J., Hernandez, J. D., … Rabinovich, G. A. (2007). Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nature Immunology, 8(8), 825-834. doi: 10.1038/ni1482.
van Kooyk, Y., & Rabinovich, G. A. (2008). Protein-glycan interactions in the control of innate and adaptive immune responses. Nature Immunology, 9(6), 593-601. doi: 10.1038/ni.f.203.
Vasta, G. R. (2012). Galectins as pattern recognition receptors: Structure, function, and evolution. Advances in Experimental Medicine and Biology, 946, 21-36. doi: 10.1007/978-1-4614-0106-3_2.
Wada, J., & Kanwar, Y. S. (1997). Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. Journal of Biological Chemistry, 272(9), 6078-6086. doi: 10.1074/jbc.272.9.6078.
Whitney, P. L., Powell, J. T., & Sanford, G. L. (1986). Oxidation and chemical modification of lung beta-galactoside-specific lectin. Biochemical Journal, 238(3), 683-689.

Auteurs

Shang-Chuen Wu (SC)

Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Anu Paul (A)

Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Alex Ho (A)

Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Kashyap R Patel (KR)

Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Jerry William Lynn Allen (JWL)

Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Hans Verkerke (H)

Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia.

Connie M Arthur (CM)

Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia.

Sean R Stowell (SR)

Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH